Since the outset of the COVID-19 pandemic, 10 to 30 per cent of the general population has experienced some form of virus-induced cognitive impairment, including trouble concentrating, brain fog or memory loss.
Taysha raises $150M PIPE, shares single patient data on Rett syndrome gene therapy
Taysha Gene Therapies announced it raised $150 million from a stock sale to investors as it unveiled data from a single Rett syndrome patient who
August 15, 2023